logo-loader
Proactive logo live
Endeavour Mining PLC -
What brokers say
Some smaller miners 'clearly mispriced', analyst says, gold still 'the place to be'

Gold equities are the “place to be”, said analysts at Berenberg in a review of the mining...

12 minutes ago
What brokers say

AFC entering a ‘year of delivery’, says Liberum

Liberum has reaffirmed its ‘buy’ rating on AFC Energy PLC (AIM:AFC, OTC:AFGYF) as the hydrogen...

14 minutes ago
Big caps

Big tech outperformance coming to an end, says broker

Big Tech firms are likely coming to the end of a trend in which they outperform market...

1 hour, 8 minutes ago
Mid caps

bluebird bio set to outperform pessimistic expectations – broker

bluebird bio Inc (NASDAQ:BLUE), the gene therapy developer, is well-positioned to outperform...

18 hours, 26 minutes ago
Big caps

Disney able to increase shareholder returns, says broker

Walt Disney Co (NYSE:DIS, ETR:WDP) will be able to ramp up its buyback programs, grow its...

20 hours, 4 minutes ago
Psychedelics

Psychedelics stocks fly as FDA recognizes Mind Medicine's LSD drug as...

Psychedelics stocks traded higher on Thursday as investor optimism returned to the sector on the...

3 weeks ago
Insight

Nevis Brands CEO talks opportunity for THC beverage Major in California...

Nevis Brands (CSE:NEVI)' cannabis beverage product Major is now available for purchase in...

1 month ago
Artificial Intelligence

1606 Corp sees growth through strategic partnerships in March

1606 Corp. (OTC:CBDW) said in March it plans to focus on growth through strategic partnerships...

1 month ago
Small caps

Organigram and Aurora Cannabis increasingly attractive as Canopy Growth’s...

Cannabis firms OrganiGram Holdings (TSX-V:OGI, NASDAQ:OGI) and Aurora Cannabis Inc (TSX:ACB,...

1 month, 1 day ago

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

2 hours, 16 minutes ago

Join Proactive

Get ahead of the curve